lysophosphatidic acid has been researched along with tretinoin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Hagiwara-Watanabe, Y; Kaneko, Y; Kasukabe, T; Niitsu, N; Okabe-Kado, J | 1 |
2 other study(ies) available for lysophosphatidic acid and tretinoin
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
NM23 downregulation and lysophosphatidic acid receptor EDG2/lpa1 upregulation during myeloid differentiation of human leukemia cells.
Topics: Breast Neoplasms; Cell Differentiation; Down-Regulation; Female; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; K562 Cells; Leukemia; Lysophospholipids; MCF-7 Cells; Myeloid Cells; Neoplasm Proteins; NM23 Nucleoside Diphosphate Kinases; Receptors, Lysophosphatidic Acid; Tretinoin; U937 Cells; Up-Regulation | 2018 |